(Q43598370)

25 November 2017

ABCB1 polymorphisms are associated with cyclosporine-induced nephrotoxicity and gingival hyperplasia in renal transplant recipients (English)

1 reference

25 November 2017

Montserrat García

1

1 reference

25 November 2017

Rosa María Macías

2

1 reference

25 November 2017

Juan José Cubero

3

1 reference

25 November 2017

Julio Benítez

4

1 reference

25 November 2017

Francisco Caravaca

5

1 reference

25 November 2017

Guillermo Gervasini

6

1 reference

25 November 2017

11 August 2012

1 reference

European Journal of Clinical Pharmacology

25 November 2017

1 reference

25 November 2017

69

1 reference

25 November 2017

3

1 reference

25 November 2017

385-393

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-012-1355-x

25 November 2017

0 references

cites work

Clinical pharmacokinetics of cyclosporin

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

SNPStats: a web tool for the analysis of association studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

Effects of the CYP3A5*3 variant on cyclosporine exposure and acute rejection rate in renal transplant patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

Role of MDR1 gene polymorphisms in gingival overgrowth induced by cyclosporine in transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

P-glycoprotein drug transporter MDR1 gene polymorphism in renal transplant patients with and without gingival overgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

Drug-induced gingival overgrowth: old problem, new problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

MDR1 gene polymorphisms and risk of gingival hyperplasia induced by calcium antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

Association of four DNA polymorphisms with acute rejection after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

Haplotypic structure of ABCB1/MDR1 gene modifies the risk of the acute allograft rejection in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

CYP3A7, CYP3A5, CYP3A4, and ABCB1 Genetic Polymorphisms, Cyclosporine Concentration, and Dose Requirement in Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

The influence of CYP3A gene polymorphisms on cyclosporine dose requirement in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

The Effect of CYP3A5 and MDR1 Polymorphic Expression on Cyclosporine Oral Disposition in Renal Transplant Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1355-X

The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients

21 January 2018

1 reference

12 December 2020

Evaluation of the genetic background of standard-immunosuppressant-related toxicity in a cohort of 200 paediatric renal allograft recipients--a retrospective study.

1 reference

12 December 2020

Gingival overgrowth in paediatric cardiac transplant patients: a study of 19 patients aged between 2 and 16 years

1 reference

12 December 2020

Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are not associated with cyclosporine pharmacokinetics nor with cyclosporine clinical end points after renal transplantation

1 reference

12 December 2020

P-glycoprotein expression and function in circulating blood cells from normal volunteers.

1 reference

12 December 2020

No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients

1 reference

12 December 2020

The new CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with an increased risk of delayed graft function and worse renal function in cyclosporine-treated kidney transplant patients.

1 reference

12 December 2020

Human P-glycoprotein transports cyclosporin A and FK506.

1 reference

12 December 2020

Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms

1 reference

12 December 2020

Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients

1 reference

12 December 2020

CYP3A5 variant allele frequencies in Dutch Caucasians

1 reference

12 December 2020

Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation

1 reference

12 December 2020

The rôle of time in reducing gingival overgrowth in heart-transplanted patients following cyclosporin therapy

1 reference

12 December 2020

Detection of MboII polymorphism at the 5' promoter region of CYP3A4

1 reference

12 December 2020

Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation

1 reference

12 December 2020

Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium

1 reference

12 December 2020

10.1007/S00228-012-1355-X

Identifiers

DOI

1 reference

25 November 2017

1 reference